SlideShare a Scribd company logo
NATHALIE OSPINA ORTEGA
DANIELA ORTIZ PIEDRAHITA
INTRODUCTION
Brucella abortus
- intracellular bacteria
- Gram negative
- found in cattle populations
- Zoonotic
- Blood borne pathogen
- Causes premature abortion Of cattle fetus
- Causes brucellosis
Brucellosis
- signs and symptoms:
- Fever, joint pain, fatigue
- Treated with antibiotics
- Infection can recur
- No human vaccine
- killed vaccines for animal brucellosis
causes disadvantages
INTRODUCTION
immunization
- Public Health achievement
- Active: inoculation of microbial agents
- Passive: transfer of antibodies preformed
- Brucella: mucosal vaccines → l.casei
- Vectored bacterium or virus that express
exogenous antigens
lactobacillus casei
- Gram positive Lactic acid bacteria as
antigen delivery system
- Promising for mucosal immunization
- found in mouth, colon, female genital
tract
- Used for diverticulitis, diarrhea,
infections and dairy Food production
GENERAL OBJECTIVE
The aim of this study was to design a mucosal vector vaccine against
brucellosis on the basis of OMP19 antigen using Lactobacillus casei
bacterium as a vector, and evaluate the immunogenicity of this
vaccine and its protective effect against challenges with virulent
B.abortus 544 strain.
METHODS: PCR
Polymerase chain reaction
⎻ the objective of this technique is the amplification of genes or dna fragment or indirectly
through rna, present in diverse mixtures from different sources.
⎻ is based on enzymatic in vitro amplification (geometrical increase in the number of a particular
dna sequence)
⎻ this method can be used to detect tumor cells, infectious microorganisms and many others
⎻ this method was used in this article in order to achieve a vector with a protein that could be
anchored to the cell wall and being exposed to the target
⎻ IT INVOLVES VOLUNTARILY CREATING DNA MOLECULES MADE UP OF DNA FRAGMENTS FROM DIFFERENT
SOURCES.
⎻ RECOMBINING REQUIRES CUTTING AND THEN SPECIFICALLY JOINING THE DNA. THIS GENETIC
MANIPULATION WAS CARRIED OUT IN LARGE PART USING ENZYMES THAT ACT ON DNA SUCH AS RESTRICTION
ENDONUCLEASES AND LIGASES.
⎻ THIS METHOD WAS USED TO PRODUCE THE PT1NX-OMP19 RECOMBINANT PLASMID, USING THE AMPLIFIED
GENE PIECE AND DIGESTING IT WITH SUITABLE RESTRICTION ENZYMES.
METHODS:recombinant dna
METHODS:elisa
⎻ Enzymes are fixed by conjugation with compounds that have two reactive sites, one for an
antibody and one for the enzyme.
⎻ The enzymes used are: alkaline phosphatase and horseradish peroxidase
⎻ This method was used in the article to identify the specific anti-OMP19 IgA and IgG antibodies
METHODS:immunofluorescence
- IS AN ASSAY WHICH IS USED PRIMARILY ON BIOLOGICAL SAMPLES AND IS CLASSICALLY DEFINED AS A
PROCEDURE TO DETECT ANTIGENS IN CELLULAR CONTEXTS USING ANTIBODIES.
- IT USES FLUORESCENTLY LABELED SECONDARY ANTIBODIES TO VISUALIZE PROTEINS IN CELLS AND TISSUES,
AND CAN PROVIDE INFORMATION ABOUT THE TISSUE DISTRIBUTION OF A GIVEN PROTEIN AS WELL AS ITS
SUBCELLULAR DISTRIBUTION.
- THIS METHOD WAS USED TO DEMONSTRATE THE EXPRESSION OF OMP19 PROTEIN ON THE SURFACE OF
RECOMBINANT L. CASEI BACTERIUM.
RESULTS
RESULTS
RESULTS
RESULTS
AUTHOR AFFIRMATION AGREES / DISAGREES
Farahi et al he investigated the capacity of brucella
abortus. omp19 to elicit splenic
lymphocytes stimulation response
Pasquevich et al he evaluated the potential of brucella
abortus OMP19 as a suitable subunit
vaccine against brucellosis
Ribeiro LA et al he constructed a L. lactis strain
producing recombinant B. abortus
L7/L12 antigen as a first step towards
food-grade live vaccines against
brucellosis
DISCUSSION
CONCLUSIONS
- brucella infections generally happen via mucosal surfaces, therefore, the expansion of mucosal
administered vaccines could be beneficial to controlling brucellosis at pathogen entry location
- In lactic acid bacteria, probiotic Lactobacillus casei is considered as a promising antigen delivery
system for mucosal immunization, and it could help with others illnesses.
- Oral immunization with recombinant probiotic Lactobacillus casei vector vaccine expressing
OMP19 stimulates the immunity of mucosal and systemic, hence the fact that the vaccine produced
in this research could be a very good candidate for the development of a vaccine against human
and animal brucellosis.
CONCEPTUAL MAP: NATHALIE OSPINA
CONCEPTUAL MAP: DANIELA ORTIZ

More Related Content

What's hot

Cephalosporins
CephalosporinsCephalosporins
Cephalosporins
Marina Ibrahim
 
6 beta lactum drugs dental
6  beta lactum drugs dental6  beta lactum drugs dental
6 beta lactum drugs dental
IAU Dent
 
Cephalosporins
CephalosporinsCephalosporins
Cephalosporins 2
Cephalosporins 2Cephalosporins 2
Cephalosporins 2osamaDR
 
Cephalosporins
CephalosporinsCephalosporins
Cephalosporins
Dr Vinay Gupta
 
Cephalosporins penems
Cephalosporins  penemsCephalosporins  penems
Cephalosporins penemssuniu
 
Antisense inhibition of lpxB gene expression in Acinetobacter baumannii by pe...
Antisense inhibition of lpxB gene expression in Acinetobacter baumannii by pe...Antisense inhibition of lpxB gene expression in Acinetobacter baumannii by pe...
Antisense inhibition of lpxB gene expression in Acinetobacter baumannii by pe...
juanjosegiraldo5
 
Antisense inhibition of lpxB gene expression in Acinetobacter baumannii by pe...
Antisense inhibition of lpxB gene expression in Acinetobacter baumannii by pe...Antisense inhibition of lpxB gene expression in Acinetobacter baumannii by pe...
Antisense inhibition of lpxB gene expression in Acinetobacter baumannii by pe...
juanjosegiraldo5
 
Beta lactam antibiotics(Penicillin, Cephalosporin)
Beta lactam antibiotics(Penicillin, Cephalosporin)Beta lactam antibiotics(Penicillin, Cephalosporin)
Beta lactam antibiotics(Penicillin, Cephalosporin)
BikashAdhikari26
 
Beta lactam antibiotic cephalosporin
Beta lactam antibiotic cephalosporinBeta lactam antibiotic cephalosporin
Beta lactam antibiotic cephalosporin
SMS MEDICAL COLLEGE
 
Fifth generation cephalosporins 2011
Fifth generation cephalosporins 2011 Fifth generation cephalosporins 2011
Fifth generation cephalosporins 2011 PathKind Labs
 
Cephalosporins
CephalosporinsCephalosporins
Cephalosporins
Abhay Rajpoot
 
beta lactam antibiotics,aminoglycosides, quinolones and macrolide antibiotics
beta lactam antibiotics,aminoglycosides, quinolones and macrolide antibioticsbeta lactam antibiotics,aminoglycosides, quinolones and macrolide antibiotics
beta lactam antibiotics,aminoglycosides, quinolones and macrolide antibiotics
mohammed muzammil
 
Antibiotics in Egyptian pharmacies
Antibiotics in Egyptian pharmaciesAntibiotics in Egyptian pharmacies
Antibiotics in Egyptian pharmacies
Ahmed Gamal Afify
 

What's hot (16)

antibiotics
antibioticsantibiotics
antibiotics
 
Cephalosporins
CephalosporinsCephalosporins
Cephalosporins
 
6 beta lactum drugs dental
6  beta lactum drugs dental6  beta lactum drugs dental
6 beta lactum drugs dental
 
Cephalosporins
CephalosporinsCephalosporins
Cephalosporins
 
Cephalosporins 2
Cephalosporins 2Cephalosporins 2
Cephalosporins 2
 
Cephalosporins
CephalosporinsCephalosporins
Cephalosporins
 
Cephalosporins penems
Cephalosporins  penemsCephalosporins  penems
Cephalosporins penems
 
Antisense inhibition of lpxB gene expression in Acinetobacter baumannii by pe...
Antisense inhibition of lpxB gene expression in Acinetobacter baumannii by pe...Antisense inhibition of lpxB gene expression in Acinetobacter baumannii by pe...
Antisense inhibition of lpxB gene expression in Acinetobacter baumannii by pe...
 
Antisense inhibition of lpxB gene expression in Acinetobacter baumannii by pe...
Antisense inhibition of lpxB gene expression in Acinetobacter baumannii by pe...Antisense inhibition of lpxB gene expression in Acinetobacter baumannii by pe...
Antisense inhibition of lpxB gene expression in Acinetobacter baumannii by pe...
 
Beta lactam antibiotics(Penicillin, Cephalosporin)
Beta lactam antibiotics(Penicillin, Cephalosporin)Beta lactam antibiotics(Penicillin, Cephalosporin)
Beta lactam antibiotics(Penicillin, Cephalosporin)
 
Beta lactam antibiotic cephalosporin
Beta lactam antibiotic cephalosporinBeta lactam antibiotic cephalosporin
Beta lactam antibiotic cephalosporin
 
cepha;osporins
cepha;osporinscepha;osporins
cepha;osporins
 
Fifth generation cephalosporins 2011
Fifth generation cephalosporins 2011 Fifth generation cephalosporins 2011
Fifth generation cephalosporins 2011
 
Cephalosporins
CephalosporinsCephalosporins
Cephalosporins
 
beta lactam antibiotics,aminoglycosides, quinolones and macrolide antibiotics
beta lactam antibiotics,aminoglycosides, quinolones and macrolide antibioticsbeta lactam antibiotics,aminoglycosides, quinolones and macrolide antibiotics
beta lactam antibiotics,aminoglycosides, quinolones and macrolide antibiotics
 
Antibiotics in Egyptian pharmacies
Antibiotics in Egyptian pharmaciesAntibiotics in Egyptian pharmacies
Antibiotics in Egyptian pharmacies
 

Similar to Seminario Biología Molecular

Mucosal and transdermal vaccines manju 2022.pptx
Mucosal and transdermal vaccines manju 2022.pptxMucosal and transdermal vaccines manju 2022.pptx
Mucosal and transdermal vaccines manju 2022.pptx
manjureddy62
 
Edible Vaccines
Edible VaccinesEdible Vaccines
Edible Vaccines
SurbhiSharma196
 
Dr. A. Sumathi - Mucosal Delivery of Vaccines
Dr. A. Sumathi - Mucosal Delivery of VaccinesDr. A. Sumathi - Mucosal Delivery of Vaccines
Dr. A. Sumathi - Mucosal Delivery of Vaccines
Sumathi Arumugam
 
Edible vaccines-Pharmacognosy and Phytochemistry.pptx
Edible vaccines-Pharmacognosy and Phytochemistry.pptxEdible vaccines-Pharmacognosy and Phytochemistry.pptx
Edible vaccines-Pharmacognosy and Phytochemistry.pptx
Government Pharmacy College Sajong, Government of Sikkim
 
Caries diagnosis &
Caries diagnosis &Caries diagnosis &
Caries diagnosis &
D Venkatesh Kumar
 
A-level Gene technology
A-level Gene technologyA-level Gene technology
A-level Gene technology
Bilegdemberel Magadaa
 
Presentation on conventional vaccine (Quality Control and Production aspects)
Presentation on conventional vaccine (Quality Control and Production aspects)Presentation on conventional vaccine (Quality Control and Production aspects)
Presentation on conventional vaccine (Quality Control and Production aspects)
Sunny Rathee
 
Application of rDNA technology to produce Interferon, Hepatitis-B Vaccine & I...
Application of rDNA technology to produce Interferon, Hepatitis-B Vaccine & I...Application of rDNA technology to produce Interferon, Hepatitis-B Vaccine & I...
Application of rDNA technology to produce Interferon, Hepatitis-B Vaccine & I...
Pulipati Sowjanya
 
COVID-19 vaccines details.pdf
COVID-19 vaccines details.pdfCOVID-19 vaccines details.pdf
Malaria vaccine
Malaria vaccineMalaria vaccine
Malaria vaccine
HIMANSHU JAIN
 
Grant Proposal (S00127084)
Grant Proposal (S00127084)Grant Proposal (S00127084)
Grant Proposal (S00127084)Mohammed Kazzeh
 
Vaccine delivery systems First Year M. Pharmacy.
Vaccine delivery systems  First Year M. Pharmacy.Vaccine delivery systems  First Year M. Pharmacy.
Vaccine delivery systems First Year M. Pharmacy.
Rushi Somani
 
Virosomes2
Virosomes2Virosomes2
Virosomes2
Roshan M A
 
Vaccine 5 march
Vaccine 5 march Vaccine 5 march
Vaccine 5 march
Pooja Goswami
 
ELISA Poster Presentation 2012 RCA 5 mtc
ELISA Poster Presentation 2012 RCA 5 mtcELISA Poster Presentation 2012 RCA 5 mtc
ELISA Poster Presentation 2012 RCA 5 mtcJermaine Dorsey
 
Current situation of nanovaccines technology development
Current situation of nanovaccines technology developmentCurrent situation of nanovaccines technology development
Current situation of nanovaccines technology development
DoriaFang
 
Microbiological Culture sensitivity tests
Microbiological Culture sensitivity testsMicrobiological Culture sensitivity tests
Microbiological Culture sensitivity tests
Dr Vimali
 
Mucosal dds
Mucosal ddsMucosal dds
Mucosal dds
JanardanKhandekar
 

Similar to Seminario Biología Molecular (20)

Mucosal and transdermal vaccines manju 2022.pptx
Mucosal and transdermal vaccines manju 2022.pptxMucosal and transdermal vaccines manju 2022.pptx
Mucosal and transdermal vaccines manju 2022.pptx
 
Edible Vaccines
Edible VaccinesEdible Vaccines
Edible Vaccines
 
Dr. A. Sumathi - Mucosal Delivery of Vaccines
Dr. A. Sumathi - Mucosal Delivery of VaccinesDr. A. Sumathi - Mucosal Delivery of Vaccines
Dr. A. Sumathi - Mucosal Delivery of Vaccines
 
Edible vaccines-Pharmacognosy and Phytochemistry.pptx
Edible vaccines-Pharmacognosy and Phytochemistry.pptxEdible vaccines-Pharmacognosy and Phytochemistry.pptx
Edible vaccines-Pharmacognosy and Phytochemistry.pptx
 
Caries diagnosis &
Caries diagnosis &Caries diagnosis &
Caries diagnosis &
 
A-level Gene technology
A-level Gene technologyA-level Gene technology
A-level Gene technology
 
Presentation on conventional vaccine (Quality Control and Production aspects)
Presentation on conventional vaccine (Quality Control and Production aspects)Presentation on conventional vaccine (Quality Control and Production aspects)
Presentation on conventional vaccine (Quality Control and Production aspects)
 
Application of rDNA technology to produce Interferon, Hepatitis-B Vaccine & I...
Application of rDNA technology to produce Interferon, Hepatitis-B Vaccine & I...Application of rDNA technology to produce Interferon, Hepatitis-B Vaccine & I...
Application of rDNA technology to produce Interferon, Hepatitis-B Vaccine & I...
 
COVID-19 vaccines details.pdf
COVID-19 vaccines details.pdfCOVID-19 vaccines details.pdf
COVID-19 vaccines details.pdf
 
Malaria vaccine
Malaria vaccineMalaria vaccine
Malaria vaccine
 
Grant Proposal (S00127084)
Grant Proposal (S00127084)Grant Proposal (S00127084)
Grant Proposal (S00127084)
 
Vaccine delivery systems First Year M. Pharmacy.
Vaccine delivery systems  First Year M. Pharmacy.Vaccine delivery systems  First Year M. Pharmacy.
Vaccine delivery systems First Year M. Pharmacy.
 
Virosomes2
Virosomes2Virosomes2
Virosomes2
 
Vaccine 5 march
Vaccine 5 march Vaccine 5 march
Vaccine 5 march
 
ELISA Poster Presentation 2012 RCA 5 mtc
ELISA Poster Presentation 2012 RCA 5 mtcELISA Poster Presentation 2012 RCA 5 mtc
ELISA Poster Presentation 2012 RCA 5 mtc
 
PhD_presentation_glenting
PhD_presentation_glentingPhD_presentation_glenting
PhD_presentation_glenting
 
Current situation of nanovaccines technology development
Current situation of nanovaccines technology developmentCurrent situation of nanovaccines technology development
Current situation of nanovaccines technology development
 
Microbiological Culture sensitivity tests
Microbiological Culture sensitivity testsMicrobiological Culture sensitivity tests
Microbiological Culture sensitivity tests
 
Mucosal dds
Mucosal ddsMucosal dds
Mucosal dds
 
Final Paper
Final PaperFinal Paper
Final Paper
 

Recently uploaded

June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
Levi Shapiro
 
Digital Artifact 2 - Investigating Pavilion Designs
Digital Artifact 2 - Investigating Pavilion DesignsDigital Artifact 2 - Investigating Pavilion Designs
Digital Artifact 2 - Investigating Pavilion Designs
chanes7
 
S1-Introduction-Biopesticides in ICM.pptx
S1-Introduction-Biopesticides in ICM.pptxS1-Introduction-Biopesticides in ICM.pptx
S1-Introduction-Biopesticides in ICM.pptx
tarandeep35
 
Thesis Statement for students diagnonsed withADHD.ppt
Thesis Statement for students diagnonsed withADHD.pptThesis Statement for students diagnonsed withADHD.ppt
Thesis Statement for students diagnonsed withADHD.ppt
EverAndrsGuerraGuerr
 
The Accursed House by Émile Gaboriau.pptx
The Accursed House by Émile Gaboriau.pptxThe Accursed House by Émile Gaboriau.pptx
The Accursed House by Émile Gaboriau.pptx
DhatriParmar
 
The basics of sentences session 5pptx.pptx
The basics of sentences session 5pptx.pptxThe basics of sentences session 5pptx.pptx
The basics of sentences session 5pptx.pptx
heathfieldcps1
 
The approach at University of Liverpool.pptx
The approach at University of Liverpool.pptxThe approach at University of Liverpool.pptx
The approach at University of Liverpool.pptx
Jisc
 
The Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official PublicationThe Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official Publication
Delapenabediema
 
Group Presentation 2 Economics.Ariana Buscigliopptx
Group Presentation 2 Economics.Ariana BuscigliopptxGroup Presentation 2 Economics.Ariana Buscigliopptx
Group Presentation 2 Economics.Ariana Buscigliopptx
ArianaBusciglio
 
Overview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with MechanismOverview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with Mechanism
DeeptiGupta154
 
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
EugeneSaldivar
 
Digital Tools and AI for Teaching Learning and Research
Digital Tools and AI for Teaching Learning and ResearchDigital Tools and AI for Teaching Learning and Research
Digital Tools and AI for Teaching Learning and Research
Vikramjit Singh
 
2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...
Sandy Millin
 
Francesca Gottschalk - How can education support child empowerment.pptx
Francesca Gottschalk - How can education support child empowerment.pptxFrancesca Gottschalk - How can education support child empowerment.pptx
Francesca Gottschalk - How can education support child empowerment.pptx
EduSkills OECD
 
The French Revolution Class 9 Study Material pdf free download
The French Revolution Class 9 Study Material pdf free downloadThe French Revolution Class 9 Study Material pdf free download
The French Revolution Class 9 Study Material pdf free download
Vivekanand Anglo Vedic Academy
 
"Protectable subject matters, Protection in biotechnology, Protection of othe...
"Protectable subject matters, Protection in biotechnology, Protection of othe..."Protectable subject matters, Protection in biotechnology, Protection of othe...
"Protectable subject matters, Protection in biotechnology, Protection of othe...
SACHIN R KONDAGURI
 
Welcome to TechSoup New Member Orientation and Q&A (May 2024).pdf
Welcome to TechSoup   New Member Orientation and Q&A (May 2024).pdfWelcome to TechSoup   New Member Orientation and Q&A (May 2024).pdf
Welcome to TechSoup New Member Orientation and Q&A (May 2024).pdf
TechSoup
 
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
MysoreMuleSoftMeetup
 
special B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdfspecial B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdf
Special education needs
 
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdfUnit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Thiyagu K
 

Recently uploaded (20)

June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
 
Digital Artifact 2 - Investigating Pavilion Designs
Digital Artifact 2 - Investigating Pavilion DesignsDigital Artifact 2 - Investigating Pavilion Designs
Digital Artifact 2 - Investigating Pavilion Designs
 
S1-Introduction-Biopesticides in ICM.pptx
S1-Introduction-Biopesticides in ICM.pptxS1-Introduction-Biopesticides in ICM.pptx
S1-Introduction-Biopesticides in ICM.pptx
 
Thesis Statement for students diagnonsed withADHD.ppt
Thesis Statement for students diagnonsed withADHD.pptThesis Statement for students diagnonsed withADHD.ppt
Thesis Statement for students diagnonsed withADHD.ppt
 
The Accursed House by Émile Gaboriau.pptx
The Accursed House by Émile Gaboriau.pptxThe Accursed House by Émile Gaboriau.pptx
The Accursed House by Émile Gaboriau.pptx
 
The basics of sentences session 5pptx.pptx
The basics of sentences session 5pptx.pptxThe basics of sentences session 5pptx.pptx
The basics of sentences session 5pptx.pptx
 
The approach at University of Liverpool.pptx
The approach at University of Liverpool.pptxThe approach at University of Liverpool.pptx
The approach at University of Liverpool.pptx
 
The Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official PublicationThe Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official Publication
 
Group Presentation 2 Economics.Ariana Buscigliopptx
Group Presentation 2 Economics.Ariana BuscigliopptxGroup Presentation 2 Economics.Ariana Buscigliopptx
Group Presentation 2 Economics.Ariana Buscigliopptx
 
Overview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with MechanismOverview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with Mechanism
 
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
 
Digital Tools and AI for Teaching Learning and Research
Digital Tools and AI for Teaching Learning and ResearchDigital Tools and AI for Teaching Learning and Research
Digital Tools and AI for Teaching Learning and Research
 
2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...
 
Francesca Gottschalk - How can education support child empowerment.pptx
Francesca Gottschalk - How can education support child empowerment.pptxFrancesca Gottschalk - How can education support child empowerment.pptx
Francesca Gottschalk - How can education support child empowerment.pptx
 
The French Revolution Class 9 Study Material pdf free download
The French Revolution Class 9 Study Material pdf free downloadThe French Revolution Class 9 Study Material pdf free download
The French Revolution Class 9 Study Material pdf free download
 
"Protectable subject matters, Protection in biotechnology, Protection of othe...
"Protectable subject matters, Protection in biotechnology, Protection of othe..."Protectable subject matters, Protection in biotechnology, Protection of othe...
"Protectable subject matters, Protection in biotechnology, Protection of othe...
 
Welcome to TechSoup New Member Orientation and Q&A (May 2024).pdf
Welcome to TechSoup   New Member Orientation and Q&A (May 2024).pdfWelcome to TechSoup   New Member Orientation and Q&A (May 2024).pdf
Welcome to TechSoup New Member Orientation and Q&A (May 2024).pdf
 
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
 
special B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdfspecial B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdf
 
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdfUnit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdf
 

Seminario Biología Molecular

  • 2. INTRODUCTION Brucella abortus - intracellular bacteria - Gram negative - found in cattle populations - Zoonotic - Blood borne pathogen - Causes premature abortion Of cattle fetus - Causes brucellosis Brucellosis - signs and symptoms: - Fever, joint pain, fatigue - Treated with antibiotics - Infection can recur - No human vaccine - killed vaccines for animal brucellosis causes disadvantages
  • 3. INTRODUCTION immunization - Public Health achievement - Active: inoculation of microbial agents - Passive: transfer of antibodies preformed - Brucella: mucosal vaccines → l.casei - Vectored bacterium or virus that express exogenous antigens lactobacillus casei - Gram positive Lactic acid bacteria as antigen delivery system - Promising for mucosal immunization - found in mouth, colon, female genital tract - Used for diverticulitis, diarrhea, infections and dairy Food production
  • 4. GENERAL OBJECTIVE The aim of this study was to design a mucosal vector vaccine against brucellosis on the basis of OMP19 antigen using Lactobacillus casei bacterium as a vector, and evaluate the immunogenicity of this vaccine and its protective effect against challenges with virulent B.abortus 544 strain.
  • 5. METHODS: PCR Polymerase chain reaction ⎻ the objective of this technique is the amplification of genes or dna fragment or indirectly through rna, present in diverse mixtures from different sources. ⎻ is based on enzymatic in vitro amplification (geometrical increase in the number of a particular dna sequence) ⎻ this method can be used to detect tumor cells, infectious microorganisms and many others ⎻ this method was used in this article in order to achieve a vector with a protein that could be anchored to the cell wall and being exposed to the target
  • 6. ⎻ IT INVOLVES VOLUNTARILY CREATING DNA MOLECULES MADE UP OF DNA FRAGMENTS FROM DIFFERENT SOURCES. ⎻ RECOMBINING REQUIRES CUTTING AND THEN SPECIFICALLY JOINING THE DNA. THIS GENETIC MANIPULATION WAS CARRIED OUT IN LARGE PART USING ENZYMES THAT ACT ON DNA SUCH AS RESTRICTION ENDONUCLEASES AND LIGASES. ⎻ THIS METHOD WAS USED TO PRODUCE THE PT1NX-OMP19 RECOMBINANT PLASMID, USING THE AMPLIFIED GENE PIECE AND DIGESTING IT WITH SUITABLE RESTRICTION ENZYMES. METHODS:recombinant dna
  • 7. METHODS:elisa ⎻ Enzymes are fixed by conjugation with compounds that have two reactive sites, one for an antibody and one for the enzyme. ⎻ The enzymes used are: alkaline phosphatase and horseradish peroxidase ⎻ This method was used in the article to identify the specific anti-OMP19 IgA and IgG antibodies
  • 8. METHODS:immunofluorescence - IS AN ASSAY WHICH IS USED PRIMARILY ON BIOLOGICAL SAMPLES AND IS CLASSICALLY DEFINED AS A PROCEDURE TO DETECT ANTIGENS IN CELLULAR CONTEXTS USING ANTIBODIES. - IT USES FLUORESCENTLY LABELED SECONDARY ANTIBODIES TO VISUALIZE PROTEINS IN CELLS AND TISSUES, AND CAN PROVIDE INFORMATION ABOUT THE TISSUE DISTRIBUTION OF A GIVEN PROTEIN AS WELL AS ITS SUBCELLULAR DISTRIBUTION. - THIS METHOD WAS USED TO DEMONSTRATE THE EXPRESSION OF OMP19 PROTEIN ON THE SURFACE OF RECOMBINANT L. CASEI BACTERIUM.
  • 13. AUTHOR AFFIRMATION AGREES / DISAGREES Farahi et al he investigated the capacity of brucella abortus. omp19 to elicit splenic lymphocytes stimulation response Pasquevich et al he evaluated the potential of brucella abortus OMP19 as a suitable subunit vaccine against brucellosis Ribeiro LA et al he constructed a L. lactis strain producing recombinant B. abortus L7/L12 antigen as a first step towards food-grade live vaccines against brucellosis DISCUSSION
  • 14. CONCLUSIONS - brucella infections generally happen via mucosal surfaces, therefore, the expansion of mucosal administered vaccines could be beneficial to controlling brucellosis at pathogen entry location - In lactic acid bacteria, probiotic Lactobacillus casei is considered as a promising antigen delivery system for mucosal immunization, and it could help with others illnesses. - Oral immunization with recombinant probiotic Lactobacillus casei vector vaccine expressing OMP19 stimulates the immunity of mucosal and systemic, hence the fact that the vaccine produced in this research could be a very good candidate for the development of a vaccine against human and animal brucellosis.